iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Price to FCF (2009 - 2012)

Updated

iBio's (IBIO) Price to FCF was 342.82 for fiscal Q3 2012 (quarter ended Mar 31, 2012).

Analysis

iBio (IBIO) Price to FCF (2009 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 iBio 118.23 Mn -174.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 342.82
Mar 31, 2010 277.30
Dec 31, 2009 174.49
Sep 30, 2009 234.14
Jun 30, 2009 89.39
API Access

iBio Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=IBIO&period=max&api_key=YOUR_API_KEY